News
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
A WOMAN who weighed 12st 10lbs and was a size 16 decided to try the weight loss jab after struggling to stick to diets, but things weren’t as perfect as she’d hoped. Kathleen Smith, ...
Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...
Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results